We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest App Notes & Case Studies

Illustration of a neuron with axon and dendrites, representing nerve cell communication, linked to rare disease drug discovery.
App Note / Case Study

Advancing Rare Disease Drug Discovery Using Consistent, Defined Human Cells

This case study examines how deterministic cell programming technology provides the consistent, defined human neurons necessary to progress toward potential therapies for neurodevelopmental disorders.
ProPure logo centered on a black background, surrounded by floating blue and green crystal shapes with glowing white light points
App Note / Case Study

Endotoxin-Free Proteins Made in the USA

The PDF advertisement showcases the superior properties of Sino Biological's endotoxin-free protein
Sino Biological ProPure™ endotoxin-free proteins flyer highlighting high purity, U.S. manufacturing, quality assurance, and product features
App Note / Case Study

ProPure™ Endotoxin-Free Proteins

This flyer mainly introduces the advantages of Sino Biological's endotoxin-free protein, the product's quality assurance, and featured products.
Open magazine spread by Sino Biological showcasing ProPure branding, endotoxin-free protein research visuals, and technical charts
App Note / Case Study

ProPure™: Raising the Bar in Life Science Research

ProPure™ endotoxin-free recombinant proteins from Sino Biological empower researchers and industry professionals to perform at the highest standards, bolstering scientific excellence while minimizing risk.
Open magazine spread featuring Sino Biological: lab team in cleanroom gear on left, bioprocessing facility and text on right.
App Note / Case Study

The Evolution of Bioprocessing: Bridging Global Expertise With Local Innovation

Sino Biological's C4B in Houston uses advanced protein and antibody production platforms, global expertise, and regional manufacturing capacity to accelerate drug discovery and reduce logistical barriers for biopharmaceutical partners.
Application note on screening 3D spheroids with next-generation high-content imaging, featuring spheroid fluorescence imagery and Molecular Devices branding
App Note / Case Study

Screening of 3D Spheroids Using a Robust, Sensitive, Next-Generation High Content Imager

Image-based high-content screening enables drug discovery by quantifying cellular changes. With growing use of 3D spheroid models, advanced imaging and analysis platforms are essential for accurate assessment of drug response
IN Carta image analysis software shown on a lab workstation, displaying quantitative cell imaging results beside a Molecular Devices instrument
App Note / Case Study

IN Carta Image Analysis Software

Go from assay to insights quickly and reliably with ImageXpress imaging systems and IN Carta software
Application note cover on high-speed phenotypic profiling with AI-enabled high-content imaging, featuring cell images and Molecular Devices branding
App Note / Case Study

High-Speed Phenotypic Profiling Using a Next Generation High-Content Imaging Platform With AI-Enabled Image Analysis

In this application note, we present two representative assays to demonstrate how the newly engineered imager and its modern software interface enable a streamlined, end-to-end workflow—from acquisition setup to advanced data analysis
ImageXpress HCS.ai high-content screening system with fluorescence cell imagery and Molecular Devices branding
App Note / Case Study

ImageXpress HCS.ai High-Content Screening System

The ImageXpress® HCS.ai High-Content Screening System captures your imagination with high-quality imaging and analysis, enabling you to acquire the data you need with ease
Digital workflow graphic illustrating high-throughput CE-SDS data processing and integrity.
App Note / Case Study

Achieving High-Throughput CE-SDS While Preserving Data Integrity

This case study outlines a validated approach for implementing high-throughput CE-SDS while maintaining existing SOPs and regulatory compliance across a global organization.
Advertisement